(AS) Amer Sports - Overview
Sector: Consumer Cyclical | Industry: Leisure | Exchange: NYSE (USA) | Market Cap: 20.515m USD | Total Return: -3.5% in 12m
Avg Turnover: 136M
Qual. Beats: 0
Rev. Trend: 99.2%
Warnings
No concerns identified
Tailwinds
Confidence
Amer Sports, Inc. (NYSE: AS) is a global designer and distributor of premium sports equipment, apparel, and footwear. Headquartered in Helsinki, the company manages a diverse portfolio of specialized brands, including Arcteryx, Salomon, Wilson, and Atomic. Its operations are organized into three primary segments: Technical Apparel, Outdoor Performance, and Ball & Racquet Sports.
The company utilizes an omni-channel distribution strategy encompassing owned retail stores, wholesale partners, and e-commerce platforms. As a major player in the Apparel, Accessories & Luxury Goods sector, Amer Sports operates in a highly fragmented market where brand equity and technical innovation serve as primary barriers to entry. The business model relies on high-performance product cycles, catering to both professional athletes and high-end recreational consumers across North America, Europe, and Asia-Pacific.
Investors can further evaluate these brand segments and historical performance metrics on ValueRay. Given its recent corporate restructuring and 2023 rebranding, the company maintains a significant presence in specialized categories such as winter sports gear and professional-grade baseball equipment.
- Arcteryx brand expansion in Greater China drives high-margin direct-to-consumer revenue growth
- Shift toward premium technical apparel segments improves consolidated gross profit margins
- Inventory management and supply chain efficiency impact seasonal outdoor equipment profitability
- Consumer discretionary spending trends in North America influence wholesale channel demand
- Strategic shift to direct-to-consumer sales reduces dependence on traditional sporting goods retailers
| Net Income: 457.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.12 > 1.0 |
| NWC/Revenue: 18.81% < 20% (prev 17.86%; Δ 0.95% < -1%) |
| CFO/TA 0.07 > 3% & CFO 737.0m > Net Income 457.4m |
| Net Debt (1.17b) to EBITDA (1.23b): 0.96 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (572.2m) vs 12m ago 2.63% < -2% |
| Gross Margin: 58.23% > 18% (prev 0.56%; Δ 5.77k% > 0.5%) |
| Asset Turnover: 75.94% > 50% (prev 64.07%; Δ 11.88% > 0%) |
| Interest Coverage Ratio: 8.11 > 6 (EBITDA TTM 1.23b / Interest Expense TTM 100.6m) |
| A: 0.13 (Total Current Assets 3.32b - Total Current Liabilities 1.99b) / Total Assets 10.0b |
| B: -0.01 (Retained Earnings -135.8m / Total Assets 10.0b) |
| C: 0.09 (EBIT TTM 815.9m / Avg Total Assets 9.27b) |
| D: 0.81 (Book Value of Equity 2.65b / Total Liabilities 3.25b) |
| Altman-Z'' = 2.27 = BBB |
| DSRI: 1.00 (Receivables 723.9m/561.4m, Revenue 7.04b/5.46b) |
| GMI: 0.97 (GM 58.23% / 56.28%) |
| AQI: 0.90 (AQ_t 0.52 / AQ_t-1 0.58) |
| SGI: 1.29 (Revenue 7.04b / 5.46b) |
| TATA: -0.03 (NI 457.4m - CFO 737.0m) / TA 10.0b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 35.58 with a total of 3,392,171 shares traded.
Over the past week, the price has changed by +0.71%,
over one month by +3.13%,
over three months by -6.32% and
over the past year by -3.45%.
Amer Sports has received a consensus analysts rating of 4.26. Therefore, it is recommended to buy AS.
- StrongBuy: 11
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 49.7 | 39.7% |
P/E Trailing = 43.5309
P/E Forward = 27.027
P/S = 2.9144
P/B = 3.0419
P/EG = 0.7937
Revenue TTM = 7.04b USD
EBIT TTM = 815.9m USD
EBITDA TTM = 1.23b USD
Long Term Debt = 792.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 309.9m USD (from shortTermDebt, last quarter)
Debt = 1.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 856.1m
Net Debt = 1.17b USD (calculated: Debt 1.86b - CCE 683.7m)
Enterprise Value = 21.7b USD (20.5b + Debt 1.86b - CCE 683.7m)
Interest Coverage Ratio = 8.11 (Ebit TTM 815.9m / Interest Expense TTM 100.6m)
EV/FCF = 45.52x (Enterprise Value 21.7b / FCF TTM 476.5m)
FCF Yield = 2.20% (FCF TTM 476.5m / Enterprise Value 21.7b)
FCF Margin = 6.77% (FCF TTM 476.5m / Revenue TTM 7.04b)
Net Margin = 6.50% (Net Income TTM 457.4m / Revenue TTM 7.04b)
Gross Margin = 58.23% ((Revenue TTM 7.04b - Cost of Revenue TTM 2.94b) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 57.69%)
Tobins Q-Ratio = 2.17 (Enterprise Value 21.7b / Total Assets 10.0b)
Interest Expense / Debt = 5.42% (Interest Expense 100.6m / Debt 1.86b)
Taxrate = 29.30% (70.5m / 240.6m)
NOPAT = 576.8m (EBIT 815.9m * (1 - 29.30%))
Current Ratio = 1.66 (Total Current Assets 3.32b / Total Current Liabilities 1.99b)
Debt / Equity = 0.28 (Debt 1.86b / totalStockholderEquity, last quarter 6.74b)
Debt / EBITDA = 0.96 (Net Debt 1.17b / EBITDA 1.23b)
Debt / FCF = 2.46 (Net Debt 1.17b / FCF TTM 476.5m)
Total Stockholder Equity = 5.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.93% (Net Income 457.4m / Total Assets 10.0b)
RoE = 7.55% (Net Income TTM 457.4m / Total Stockholder Equity 6.06b)
RoCE = 11.91% (EBIT 815.9m / Capital Employed (Equity 6.06b + L.T.Debt 792.3m))
RoIC = 6.96% (NOPAT 576.8m / Invested Capital 8.28b)
WACC = 9.93% (E(20.5b)/V(22.4b) * Re(10.48%) + D(1.86b)/V(22.4b) * Rd(5.42%) * (1-Tc(0.29)))
Discount Rate = 10.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 7.19%
[DCF] Terminal Value 73.04% ; FCFF base≈376.0m ; Y1≈431.0m ; Y5≈634.3m
[DCF] Fair Price = 10.81 (EV 7.47b - Net Debt 1.17b = Equity 6.29b / Shares 581.8m; r=9.93% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.57 | # QB: 0
Revenue Correlation: 99.16 | Revenue CAGR: 22.09% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=+48.28% | Revisions=+33% | Analysts=13
EPS next Quarter (2026-09-30): EPS=0.38 | Chg30d=-3.16% | Revisions=+33% | Analysts=13
EPS current Year (2026-12-31): EPS=1.25 | Chg30d=+4.64% | Revisions=+56% | GrowthEPS=+29.2% | GrowthRev=+22.0%
EPS next Year (2027-12-31): EPS=1.57 | Chg30d=+4.87% | Revisions=+11% | GrowthEPS=+25.2% | GrowthRev=+13.9%
[Analyst] Revisions Ratio: +56%